Searched for
TARIFFS AND INVESTMENT
Trump says tariffs won’t hurt US economy, claims levies will bring ‘hundreds of billions of dollars’ in investmentsPresident Donald Trump defended his tariff strategy, asserting it attracts hundreds of billions in investments. He stated these tariffs rep...- Porsche to cut another 5,000 jobsPorsche will eliminate another five thousand jobs by the year 2035. This decision follows previous job cuts and is part of restructuring me...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
- Kuwait's KPC signs $16 billion lease & leaseback deal with Blackstone, KKR, Brookfield for oil pipeline networkKuwait Petroleum Corporation has signed a significant $16 billion deal for its crude oil pipeline network. This landmark agreement involves...
- Why US' Russia act need not worry IndiaThe proposed US Sanctioning Russia Act, which could impose tariffs on major buyers of Russian oil and gas, may have limited chances of beco...
- India-US 'economic partnership continues' to grow despite pending trade deal: USISPF CEO Mukesh AghiUS-India Strategic Partnership Forum (USISPF) President and Chief Executive Officer (CEO) Mukesh Aghi on Friday said that the economic part...
- Donald Trump finds a new way to impose tariffs but Asia isn't buying the reasonUS President Donald Trump's new tariffs of 10% to 12.5% on imports from 60 trading partners, including India, have sparked criticism from J...
- WTO nations query India’s PLI, QCO, import substitution, New Delhi says public policy objectives keyWTO members questioned India's trade policies at a recent review. Concerns included quality orders and abrupt tariff changes. India defende...
- Tariffs alone will not produce sustainable generic medicine in US: IPAThe Indian Pharmaceutical Alliance believes tariffs alone will not build US generic drug manufacturing. Broader reforms are needed for fair...
- South Korea says Coupang dispute not holding up US trade and security agendaA top South Korean official stated the Coupang data leak dispute is not delaying discussions with Washington. This incident involved over t...
- Generic drugmaker Sandoz to engage with US after Trump tariff threatUS President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- India engaged with the US, studying all the developments: Govt tells ParliamentThe government told Parliament it is closely monitoring developments in its trade relationship with the US and remains engaged with Washing...
Load More
